Nuformix plc (LON:NFX – Get Free Report)’s share price traded down 15.8% on Wednesday . The stock traded as low as GBX 0.08 ($0.00) and last traded at GBX 0.08 ($0.00). 21,459,072 shares traded hands during trading, a decline of 69% from the average session volume of 69,130,867 shares. The stock had previously closed at GBX 0.10 ($0.00).
Nuformix Stock Down 15.8 %
The stock has a market capitalization of £985,447.27, a P/E ratio of -2.43 and a beta of 1.22. The company has a fifty day moving average price of GBX 0.07 and a 200-day moving average price of GBX 0.08.
Nuformix (LON:NFX – Get Free Report) last issued its earnings results on Wednesday, January 29th. The company reported GBX (0.46) (($0.01)) EPS for the quarter.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Further Reading
- Five stocks we like better than Nuformix
- Compound Interest and Why It Matters When Investing
- Buffett’s on the Sidelines – Should You Follow?
- Short Selling – The Pros and Cons
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
